These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 566942)
21. Effect of calcium dobesilate on blood viscosity in diabetic microangiopathy. A review. Barras JP; Michal M Vasa; 1986; 15(3):200-5. PubMed ID: 3532608 [No Abstract] [Full Text] [Related]
22. Diabetic retinopathy and long-term therapy with Doxium 52 patients treated over periods ranging from 5--9 years. Sevin R; De Courten A Bull Ophthalmol Soc Egypt; 1978; 71(75):309-21. PubMed ID: 549725 [No Abstract] [Full Text] [Related]
23. [Use of disaggregants in treating diabetic retinopathy]. Saldan IR Oftalmol Zh; 1984; (7):395-8. PubMed ID: 6527859 [No Abstract] [Full Text] [Related]
24. Treatment for diabetic retinopathy. Drug Ther Bull; 1972 Oct; 10(22):85-7. PubMed ID: 4676365 [No Abstract] [Full Text] [Related]
25. A controlled clinical trial of calcium dobesylate in the treatment of diabetic retinopathy. Daubresse JC; Meunier R; Dumont P Diabete Metab; 1977 Mar; 3(1):27-30. PubMed ID: 323086 [TBL] [Abstract][Full Text] [Related]
26. [Diabetic retinopathy and its treatment]. Larsen HW Nord Med; 1970 Jan; 83(5):143-5. PubMed ID: 5445145 [No Abstract] [Full Text] [Related]
31. Effect of calcium bodesilate (doxium) on circulatory disorders of the retina with special emphasis on diabetic retinopathy. Németh B; Hudomel J; Farkas A Ophthalmologica; 1975; 170(5):434-45. PubMed ID: 1153166 [TBL] [Abstract][Full Text] [Related]
32. [Calcium dobesilate in the combination therapy of diabetic retinopathy]. Margolis MG; Zheleznova VF Vestn Oftalmol; 1981; (2):46-7. PubMed ID: 7233686 [No Abstract] [Full Text] [Related]
33. [The value of lipavlon in diabetic retinopathy]. François P; Belervacque A; Turut P Bull Soc Ophtalmol Fr; 1970 Apr; 70(4):568-73. PubMed ID: 5474598 [No Abstract] [Full Text] [Related]
34. [Action of calcium dobesilate on capillary fragility in diabetics]. Beretta P; Sartori F Arch Sci Med (Torino); 1977; 134(3):329-36. PubMed ID: 603392 [TBL] [Abstract][Full Text] [Related]
37. [Currently used therapeutic agents for arteriosclerosis--with special reference to a protein anabolic hormone, clofibrate (C.P.I.B.)]. Yasugi T; Sasa E Nihon Rinsho; 1970 May; 28(5):1470-4. PubMed ID: 4915308 [No Abstract] [Full Text] [Related]
38. Treatment of diabetic retinopathy. Br Med J; 1973 Aug; 3(5877):421-2. PubMed ID: 4726135 [No Abstract] [Full Text] [Related]
39. [Currently used therapeutic agents for arteriosclerosis--with special reference ro a protein anabolic hormone, clofibrate (C.P.I.B.)]. Yasugi T; Sasa E Nihon Rinsho; 1970 May; 28(5):1470-4. PubMed ID: 4916330 [No Abstract] [Full Text] [Related]
40. Hyperviscosity in whole blood, plasma, and aqueous humor decreased by doxium (calcium dobesilate) in diabetics with retinopathy and glaucoma: a double-blind controlled study. Vojnikovic B Ophthalmic Res; 1984; 16(3):150-62. PubMed ID: 6382103 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]